Cargando…
Hypoxia-Inducible Factor-1 as a Therapeutic Target in Endometrial Cancer Management
In the Western world, endometrial cancer (EC) is the most common malignant tumor of the female genital tract. Solid tumors like EC outgrow their vasculature resulting in hypoxia. Tumor hypoxia is important because it renders an aggressive phenotype and leads to radio- and chemo-therapy resistance. H...
Autores principales: | Seeber, Laura M. S., Zweemer, Ronald P., Verheijen, René H. M., van Diest, Paul J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821774/ https://www.ncbi.nlm.nih.gov/pubmed/20169098 http://dx.doi.org/10.1155/2010/580971 |
Ejemplares similares
-
Necrosis related HIF-1α expression predicts prognosis in patients with endometrioid endometrial carcinoma
por: Seeber, Laura MS, et al.
Publicado: (2010) -
Hypoxia and Angiogenesis in Endometrioid Endometrial Carcinogenesis
por: Horrée, Nicole, et al.
Publicado: (2007) -
Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast
por: Kuijper, Arno, et al.
Publicado: (2005) -
Increasing experience in laparoscopic staging of early ovarian cancer
por: Schreuder, Henk W. R., et al.
Publicado: (2011) -
Hypoxia and hypoxia inducible factor-1α are required for normal endometrial repair during menstruation
por: Maybin, Jacqueline A., et al.
Publicado: (2018)